Scarica l'app Stockscreener
56.07
2.89%
-1.67
Dopo l'orario di chiusura:
56.07
Rhythm Pharmaceuticals Inc Borsa (RYTM) Ultime notizie
Evolving Landscape of Obesity: Key Market Insights of Latest Published Different Types of Obesity | DelveInsight - GlobeNewswire Inc.
Cannon Financial Strategists Inc. Makes New Investment in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Rhythm Pharmaceuticals (NASDAQ:RYTM) Earns “Buy” Rating from Needham & Company LLC - Defense World
David P. Meeker Sells 9,896 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stock - MarketBeat
Hunter C. Smith Sells 2,215 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stock - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) EVP Jennifer Kayden Lee Sells 2,035 Shares - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CAO Christopher Paul German Sells 635 Shares - MarketBeat
Rhythm Pharmaceuticals (RYTM) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Rhythm Pharmaceuticals CAO Christopher German sells $36,334 in stock By Investing.com - Investing.com Australia
Needham & Company LLC Reiterates "Buy" Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM) - MarketBeat
Rhythm Pharmaceuticals EVP sells stock worth $116,442 By Investing.com - Investing.com Australia
Rhythm Pharmaceuticals (RYTM) Expected to Announce Quarterly Earnings on Thursday - Defense World
Rhythm pharmaceuticals CTO Joseph Shulman sells $70,266 in stock - Investing.com India
Rhythm Pharmaceuticals CEO David Meeker sells $566,249 in stock - Investing.com India
Rhythm Pharmaceuticals CAO Christopher German sells $36,334 in stock - Investing.com India
Rhythm Pharmaceuticals CFO sells $126,742 in stock By Investing.com - Investing.com South Africa
Rhythm Pharmaceuticals CFO sells $126,742 in stock - Investing.com
Rhythm Pharmaceuticals' chief human resources officer sells $56,190 in stock - Investing.com
Rhythm Pharmaceuticals CEO David Meeker sells $566,249 in stock By Investing.com - Investing.com UK
Rhythm Pharmaceuticals Executives Sell Shares - TradingView
(RYTM) Technical Pivots with Risk Controls - Stock Traders Daily
7 Analysts Assess Rhythm Pharmaceuticals: What You Need To Know - Benzinga
Buy Recommendation for Rhythm Pharmaceuticals: Promising Potential of Imcivree in Obesity Treatment - TipRanks
Investors in Rhythm Pharmaceuticals (NASDAQ:RYTM) have seen fantastic returns of 577% over the past three years - Simply Wall St
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) EVP Jennifer Kayden Lee Sells 1,815 Shares - MarketBeat
Rhythm Pharmaceuticals (RYTM) Soars 5.5%: Is Further Upside Left in the Stock? - MSN
Insider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Insider Sells 794 Shares of Stock - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) EVP Sells $246,773.99 in Stock - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CFO Sells $74,532.96 in Stock - MarketBeat
Rhythm Pharmaceuticals Executives Conduct Stock Transactions - TradingView
abrdn plc Sells 32,287 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Needham & Company LLC Weighs in on RYTM FY2029 Earnings - MarketBeat
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on ... - The Bakersfield Californian
Rhythm Pharmaceuticals to Report Fourth Quarter and Full - GlobeNewswire
Rare Disease Leader Rhythm Pharmaceuticals Sets Double Investor Events: Q4 Results & Major Healthcare Conference - StockTitan
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $68.09 Consensus Target Price from Analysts - Defense World
Research Analysts Set Expectations for RYTM FY2029 Earnings - Defense World
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Insider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CFO Sells 1,678 Shares of Stock - MarketBeat
Jennifer Kayden Lee Sells 1,447 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stock - MarketBeat
Joseph Shulman Sells 1,281 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stock - MarketBeat
Long Term Trading Analysis for (RYTM) - Stock Traders Daily
KBC Group NV Buys 988 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Insider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CEO Sells 4,278 Shares of Stock - MarketBeat
JGP Global Gestao de Recursos Ltda. Has $301,000 Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
RYTMRhythm Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
RYTM (Rhythm Pharmaceuticals) Enterprise Value : $3,390.0 Mil (As of Feb. 05, 2025) - GuruFocus.com
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):